Mineralocorticoid receptor antagonists reduce risk of cardiovascular events in patients with heart failure Post author: Post published:September 3, 2024 Post category:uncategorized MRAs significantly lower the risk of cardiovascular death and HF hospitalization in heart failure patients. You Might Also Like Smartwatches may overestimate calories burned during exercise September 1, 2026 Gaps in HPV cancer screening and prevention identified for people living with HIV March 12, 2025 Listen: NPR and KFF Health News explore how racism and violence hurt health January 6, 2025